On February 21, 2023 Nordic Nanovector ASA (OSE: NANOV) reported that it will report its results for the second half and full year 2022 on Tuesday, 28 February 2023 (Press release, Nordic Nanovector, FEB 21, 2023, View Source [SID1234627490]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A presentation by Nordic Nanovector’s interim CEO & CFO, Ludvik Sandnes, will be held in-person and webcast live beginning at 8:30am CET.

VENUE: ADVOKATFIRMAET CLP DA, Sommerrogata 13, 0255 Oslo

Questions can be submitted in advance to [email protected]

The webcast can be accessed from www.nordicnanovector.com in the section: Investors & Media and a recording will also be available on this page after the event.

The results report and the presentation will be available at www.nordicnanovector.com in the section: Investors & Media/Reports and Presentation/Interim Reports/2022 from 7:00am CET the same day.

IR enquiries

Ludvik Sandnes, Interim CEO & CFO
+47 907 43 017
[email protected]